Alder Biopharmaceuticals Inc. (ALDR)

18.88
0.04 0.21
NASDAQ : Health Technology
Prev Close 18.92
Open 18.95
Day Low/High 18.82 / 19.12
52 Wk Low/High 8.39 / 19.12
Volume 29.17M
Avg Volume 3.01M
Exchange NASDAQ
Shares Outstanding 83.64M
Market Cap 1.58B
EPS -4.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: WeissLaw LLP Investigates Alder Biopharmaceuticals, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Alder Biopharmaceuticals, Inc.

NEW YORK, Sept. 17, 2019 /PRNewswire/ --  WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Alder Biopharmaceuticals, Inc.

Notable Monday Option Activity: ALDR, JYNT, TOL

Notable Monday Option Activity: ALDR, JYNT, TOL

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alder Biopharmaceuticals Inc , where a total of 26,749 contracts have traded so far, representing approximately 2.7 million underlying shares. That amounts to about 446.1% of ALDR's average daily trading volume over the past month of 599,555 shares.

Shareholder Alert: Ademi & O'Reilly, LLP Investigates Whether Alder BioPharmaceuticals Has Obtained A Fair Price In Its Sale To H. Lundbeck A/S

Shareholder Alert: Ademi & O'Reilly, LLP Investigates Whether Alder BioPharmaceuticals Has Obtained A Fair Price In Its Sale To H. Lundbeck A/S

MILWAUKEE, Sept. 16, 2019 /PRNewswire/ -- Ademi & O'Reilly, LLP is investigating Alder (Nasdaq: ALDR) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Alder to H.

Alder Biopharmaceuticals Surges on Lundbeck Offer

Alder Biopharmaceuticals Surges on Lundbeck Offer

Alder Biopharmaceuticals surges after rival Danish drugmaker Lundbeck announces plans to acquire the company and its late-stage migraine drug eptinezumab in a deal worth up to $1.95 billion.

Alder (ALDR) Alert: Johnson Fistel Investigates Proposed Sale Of Alder BioPharmaceuticals, Inc.; Are Shareholders Getting A Fair Deal?

Alder (ALDR) Alert: Johnson Fistel Investigates Proposed Sale Of Alder BioPharmaceuticals, Inc.; Are Shareholders Getting A Fair Deal?

SAN DIEGO, Sept. 16, 2019 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Alder BioPharmaceuticals, Inc.

Bolt Biotherapeutics Appoints Veteran Executive Randall Schatzman As CEO To Lead The Next Phase Of Growth

Bolt Biotherapeutics Appoints Veteran Executive Randall Schatzman As CEO To Lead The Next Phase Of Growth

-- Immune-stimulating Antibody Conjugate (ISAC) Immunotherapy Technology Attracts Seasoned Biotech Business Leader --

Alder Biopharmaceuticals Becomes Oversold (ALDR)

Alder Biopharmaceuticals Becomes Oversold (ALDR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of September 20th Options Trading For Alder Biopharmaceuticals (ALDR)

First Week Of September 20th Options Trading For Alder Biopharmaceuticals (ALDR)

Investors in Alder Biopharmaceuticals Inc saw new options begin trading this week, for the September 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALDR options chain for the new September 20th contracts and identified the following call contract of particular interest.

Go for the Easy Money: Cramer's 'Mad Money' Recap (Thursday 7/18/19)

Go for the Easy Money: Cramer's 'Mad Money' Recap (Thursday 7/18/19)

Jim Cramer says Netflix just went from being an easy-money stock to a hard-money stock. Investors need to know the difference.

Coca-Cola, Tesla, EPR Properties: 'Mad Money' Lightning Round

Coca-Cola, Tesla, EPR Properties: 'Mad Money' Lightning Round

Jim Cramer weighs in on Coca-Cola, Tesla, EPR Properties, Six Flags, Community Bank System, Alder Biopharmaceuticals and more.

First Week Of August 16th Options Trading For Alder Biopharmaceuticals (ALDR)

First Week Of August 16th Options Trading For Alder Biopharmaceuticals (ALDR)

Investors in Alder Biopharmaceuticals Inc saw new options begin trading this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALDR options chain for the new August 16th contracts and identified one put and one call contract of particular interest.

Interesting ALDR Put And Call Options For January 2020

Interesting ALDR Put And Call Options For January 2020

Investors in Alder Biopharmaceuticals Inc saw new options become available this week, for the January 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Alder Biopharmaceuticals Is Now Oversold (ALDR)

Alder Biopharmaceuticals Is Now Oversold (ALDR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of June 21st Options Trading For Alder Biopharmaceuticals (ALDR)

First Week Of June 21st Options Trading For Alder Biopharmaceuticals (ALDR)

Investors in Alder Biopharmaceuticals Inc saw new options become available this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALDR options chain for the new June 21st contracts and identified the following call contract of particular interest.

Markets Begin Monday Lower; Amgen and Lam Research Updates

A look at Amgen's dispute with Novartis as well as Lam Research stock.

Bullish Jobs Data: Cramer's 'Mad Money' Recap (Friday 4/5/19)

Bullish Jobs Data: Cramer's 'Mad Money' Recap (Friday 4/5/19)

It's the right amount of growth and wage gains, says Jim Cramer. And here's your game plan for next week.

First Week Of ALDR May 17th Options Trading

First Week Of ALDR May 17th Options Trading

Investors in Alder Biopharmaceuticals Inc saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALDR options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

First Week Of ALDR July 2019 Options Trading

First Week Of ALDR July 2019 Options Trading

Investors in Alder Biopharmaceuticals Inc saw new options become available this week, for the July 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 232 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Oversold Conditions For Alder Biopharmaceuticals (ALDR)

Oversold Conditions For Alder Biopharmaceuticals (ALDR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week Of ALDR April 2019 Options Trading

First Week Of ALDR April 2019 Options Trading

Investors in Alder Biopharmaceuticals Inc saw new options become available this week, for the April 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of January 2019 Options Trading For Alder Biopharmaceuticals (ALDR)

Investors in Alder Biopharmaceuticals Inc saw new options begin trading this week, for the January 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of ALDR June 15th Options Trading

Investors in Alder Biopharmaceuticals Inc saw new options become available this week, for the June 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALDR options chain for the new June 15th contracts and identified the following call contract of particular interest.

Alder Biopharmaceuticals Enters Oversold Territory (ALDR)

Alder Biopharmaceuticals Enters Oversold Territory (ALDR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of October 19th Options Trading For Alder Biopharmaceuticals (ALDR)

First Week of October 19th Options Trading For Alder Biopharmaceuticals (ALDR)

Investors in Alder Biopharmaceuticals Inc saw new options begin trading this week, for the October 19th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.